Yixuan Tian
Tianjin Key Laboratory Of Early Druggability Evaluation Of Innovative Drugs And Tianjin Key Laboratory Of Molecular Drug Research
Tianjin, 300457, China
Tianjin, 300457, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Correction: Oleanolic Acid Inhibits Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma by Promoting iNOS Dimerization.
Journal: Molecular cancer therapeutics
Published: July 10, 2024
Retraction Notice to: Tumor cell-secreted exosomal miR-22-3p inhibits transgelin and induces vascular abnormalization to promote tumor budding.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: September 28, 2022
Correction: Interaction between laminin-5γ2 and integrin β1 promotes the tumor budding of colorectal cancer via the activation of Yes-associated proteins.
Journal: Oncogene
Published: August 12, 2022
RETRACTED: Tumor cell-secreted exosomal miR-22-3p inhibits transgelin and induces vascular abnormalization to promote tumor budding.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: April 15, 2020
Correction: Interaction between laminin-5γ2 and integrin β1 promotes the tumor budding of colorectal cancer via the activation of Yes-associated proteins.
Journal: Oncogene
Published: December 06, 2019
Interaction between laminin-5γ2 and integrin β1 promotes the tumor budding of colorectal cancer via the activation of Yes-associated proteins.
Journal: Oncogene
Published: May 22, 2019
Therapeutic effects of lentinan on inflammatory bowel disease and colitis-associated cancer.
Journal: Journal of cellular and molecular medicine
Published: June 25, 2018
Oleanolic Acid Inhibits Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma by Promoting iNOS Dimerization.
Journal: Molecular cancer therapeutics
Published: May 03, 2018
Showing 1-8 of 8
Last Updated: 09/26/2026